List of Sorrento Therapeutics patents

Patents where

Current Assignee

Name

Sorrento Therapeutics

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11344709 Fluid delivery apparatus having a controller assembly and method of use		Sorrento Therapeutics	Sorrento Therapeutics	United States Patent and Trademark Office	11344709	May 31, 2022
‌ US Patent 11040183 Receptacle portion of transdermal drug delivery apparatus and methods	Patent 11040183 was granted and assigned to Sorrento Therapeutics on June, 2021 by the United States Patent and Trademark Office.	Sorrento Therapeutics	Sorrento Therapeutics	United States Patent and Trademark Office	11040183	June 22, 2021
‌ US Patent 10183156 Transdermal drug delivery device	Patent 10183156 was granted and assigned to Sorrento Therapeutics on January, 2019 by the United States Patent and Trademark Office.		Sorrento Therapeutics	United States Patent and Trademark Office	10183156	January 22, 2019
‌ US Patent 10953211 Transdermal drug delivery device	Patent 10953211 was granted and assigned to Sorrento Therapeutics on March, 2021 by the United States Patent and Trademark Office.	Sorrento Therapeutics	Sorrento Therapeutics	United States Patent and Trademark Office	10953211	March 23, 2021
‌ US Patent 9175082 Antigen binding proteins that bind PD-L1	Patent 9175082 was granted and assigned to Sorrento Therapeutics on November, 2015 by the United States Patent and Trademark Office.		Sorrento Therapeutics	United States Patent and Trademark Office	9175082	November 3, 2015
‌ US Patent 11247033 Transdermal drug delivery apparatus and methods	Patent 11247033 was granted and assigned to Sorrento Therapeutics on February, 2022 by the United States Patent and Trademark Office.	Sorrento Therapeutics	Sorrento Therapeutics	United States Patent and Trademark Office	11247033	February 15, 2022
‌ US Patent 11559674 Fluid delivery apparatus and method of assembly	Patent 11559674 was granted and assigned to Sorrento Therapeutics on January, 2023 by the United States Patent and Trademark Office.	Sorrento Therapeutics	Sorrento Therapeutics	United States Patent and Trademark Office	11559674	January 24, 2023
‌ US Patent 10058609 Antigen binding proteins that bind PD-L1	Patent 10058609 was granted and assigned to Sorrento Therapeutics on August, 2018 by the United States Patent and Trademark Office.	Sorrento Therapeutics	Sorrento Therapeutics	United States Patent and Trademark Office	10058609	August 28, 2018
‌ US Patent 10377827 Antigen binding proteins that bind c-met	Patent 10377827 was granted and assigned to Sorrento Therapeutics on August, 2019 by the United States Patent and Trademark Office.	Sorrento Therapeutics	Sorrento Therapeutics	United States Patent and Trademark Office	10377827	August 13, 2019
‌ US Patent 10328248 Controller portion of transdermal drug delivery apparatus and methods	Patent 10328248 was granted and assigned to Sorrento Therapeutics on June, 2019 by the United States Patent and Trademark Office.	Sorrento Therapeutics	Sorrento Therapeutics	United States Patent and Trademark Office	10328248	June 25, 2019
‌ US Patent 10259881 Antibody therapeutics that bind CD137	Patent 10259881 was granted and assigned to Sorrento Therapeutics on April, 2019 by the United States Patent and Trademark Office.		Sorrento Therapeutics	United States Patent and Trademark Office	10259881	April 16, 2019
‌ US Patent 10940085 Cartridge portion of transdermal drug delivery apparatus and methods	Patent 10940085 was granted and assigned to Sorrento Therapeutics on March, 2021 by the United States Patent and Trademark Office.	Sorrento Therapeutics	Sorrento Therapeutics	United States Patent and Trademark Office	10940085	March 9, 2021
‌ US Patent 11179555 Nanopatterned medical device with enhanced cellular interaction	Patent 11179555 was granted and assigned to Sorrento Therapeutics on November, 2021 by the United States Patent and Trademark Office.	Sorrento Therapeutics	Sorrento Therapeutics	United States Patent and Trademark Office	11179555	November 23, 2021
‌ US Patent 11318202 Antigen binding proteins that bind WISP1	Patent 11318202 was granted and assigned to Sorrento Therapeutics on May, 2022 by the United States Patent and Trademark Office.	Sorrento Therapeutics	Sorrento Therapeutics	United States Patent and Trademark Office	11318202	May 3, 2022
‌ US Patent 10111807 Cartridge portion of transdermal drug delivery apparatus and methods	Patent 10111807 was granted and assigned to Sorrento Therapeutics on October, 2018 by the United States Patent and Trademark Office.	Sorrento Therapeutics	Sorrento Therapeutics	United States Patent and Trademark Office	10111807	October 30, 2018
‌ US Patent 9676853 Antigen binding proteins that bind PD-1	Patent 9676853 was granted and assigned to Sorrento Therapeutics on June, 2017 by the United States Patent and Trademark Office.	Sorrento Therapeutics	Sorrento Therapeutics	United States Patent and Trademark Office	9676853	June 13, 2017
‌ US Patent 9956166 Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin	Patent 9956166 was granted and assigned to Sorrento Therapeutics on May, 2018 by the United States Patent and Trademark Office.		Sorrento Therapeutics	United States Patent and Trademark Office	9956166	May 1, 2018
‌ US Patent 11565098 Device for delivery of rheumatoid arthritis medication	Patent 11565098 was granted and assigned to Sorrento Therapeutics on January, 2023 by the United States Patent and Trademark Office.	Sorrento Therapeutics	Sorrento Therapeutics	United States Patent and Trademark Office	11565098	January 31, 2023
‌ US Patent 9902772 Antibody therapeutics that bind LAG3	Patent 9902772 was granted and assigned to Sorrento Therapeutics on February, 2018 by the United States Patent and Trademark Office.	Sorrento Therapeutics	Sorrento Therapeutics	United States Patent and Trademark Office	9902772	February 27, 2018
‌ US Patent 10232160 Transdermal drug delivery apparatus and methods	Patent 10232160 was granted and assigned to Sorrento Therapeutics on March, 2019 by the United States Patent and Trademark Office.	Sorrento Therapeutics	Sorrento Therapeutics	United States Patent and Trademark Office	10232160	March 19, 2019
‌ US Patent 11311708 Microneedle array assembly and fluid delivery apparatus having such an assembly	Patent 11311708 was granted and assigned to Sorrento Therapeutics on April, 2022 by the United States Patent and Trademark Office.	Sorrento Therapeutics	Sorrento Therapeutics	United States Patent and Trademark Office	11311708	April 26, 2022
‌ US Patent 10035855 Antibody therapeutics that bind CD47	Patent 10035855 was granted and assigned to Sorrento Therapeutics on July, 2018 by the United States Patent and Trademark Office.	Sorrento Therapeutics	Sorrento Therapeutics	United States Patent and Trademark Office	10035855	July 31, 2018
‌ US Patent 10059774 Antibody therapeutics that bind CD38	Patent 10059774 was granted and assigned to Sorrento Therapeutics on August, 2018 by the United States Patent and Trademark Office.	Sorrento Therapeutics	Sorrento Therapeutics	United States Patent and Trademark Office	10059774	August 28, 2018
‌ US Patent 9951144 Antibody therapeutics that bind CD38	Patent 9951144 was granted and assigned to Sorrento Therapeutics on April, 2018 by the United States Patent and Trademark Office.	Sorrento Therapeutics	Sorrento Therapeutics	United States Patent and Trademark Office	9951144	April 24, 2018
‌ US Patent 10245421 Nanopatterned medical device with enhanced cellular interaction	Patent 10245421 was granted and assigned to Sorrento Therapeutics on April, 2019 by the United States Patent and Trademark Office.		Sorrento Therapeutics	United States Patent and Trademark Office	10245421	April 2, 2019

...

Results per page:

109 results

0 selected

109 results

0 selected